| | | | | |
CHRS Coherus Oncology, Inc. Common Stock | €1,1824 | -3,17 % | €188,65M | €434,00K | |
| €2,3991 | +2,01 % | €187,00M | €1,39K | |
MFM Aberdeen Municipal Income Fund | €4,5317 | -0,19 % | €187,00M | €161,12K | |
CHCI Comstock Holding Companies, Inc. Class A | €17,8988 | -1,58 % | €186,99M | €32,87K | |
PTAC Patriot Acquisition Corp. Class A Ordinary Shares | €8,5990 | +0,60 % | €186,97M | €9,458 | |
ARMP Armata Pharmaceuticals, Inc. Common Stock | €5,0046 | -0,34 % | €186,72M | €38,79K | |
EXFY Expensify, Inc. Class A Common Stock | €2,0466 | +0,00 % | €186,61M | €359,05K | |
| €54,0361 | -3,05 % | €186,42M | €15,73K | |
IIF Morgan Stanley India Investment Fund, Inc. | €19,6143 | -1,17 % | €186,29M | €26,47K | |
VYGR Voyager Therapeutics, Inc. Common Stock | €2,9065 | -3,70 % | €185,97M | €274,92K | |
MITT TPG Mortgage Investment Trust, Inc. | €5,8301 | -0,29 % | €185,96M | €185,94K | |
| €1,3242 | -2,53 % | €185,50M | €875,91K | |
PEPG PepGen Inc. Common Stock | €2,7517 | +2,89 % | €185,21M | €1,63M | |
PLX Protalix BioTherapeutics, Inc. Common Stock | €2,2787 | -0,75 % | €184,98M | €758,07K | |
GSHR Gesher Acquisition Corp. II Class A Ordinary Shares | €9,0375 | -0,10 % | €184,85M | €43,14K | |
